340 related articles for article (PubMed ID: 6539309)
1. Sural nerve biopsy in leprosy patients after varying periods of treatment: histopathological and bacteriological findings on light microscopy.
Haimanot RT; Mshana RN; McDougall AC; Andersen JG
Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):163-70. PubMed ID: 6539309
[TBL] [Abstract][Full Text] [Related]
2. Muramidase (lysozyme) findings in sural and radial nerve biopsies in leprosy patients after varying periods of treatment.
Haimanot RT; McDougall AC; Mshana RN; Andersen JG; Belehu A
Int J Lepr Other Mycobact Dis; 1985 Jun; 53(2):238-46. PubMed ID: 4020211
[TBL] [Abstract][Full Text] [Related]
3. Sural nerve biopsy findings in leprosy: a qualitative and quantitative light and electron microscope study in 4 treated cases of the lepromatous spectrum.
Gibbels E; Behse F; Klingmüller G; Henke-Lübke U; Haupt WF; Gollmer E
Clin Neuropathol; 1988; 7(3):120-30. PubMed ID: 3203481
[TBL] [Abstract][Full Text] [Related]
4. Distinct histopathological patterns in single lesion leprosy patients treated with single dose therapy (ROM) in the Brazilian Multicentric Study.
Costa MB; Cavalcanti Neto PF; Martelli CM; Stefani MM; Maceira JP; Gomes MK; Schettini AP; Rebello PF; Pignataro PE; Ueda ES; Narahashi K; Scollard DM
Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):177-86. PubMed ID: 11875761
[TBL] [Abstract][Full Text] [Related]
5. Histological assessment of dermal nerve damage occurring during multidrug therapy for leprosy.
Jain M; Singh N; Bhatia A; Arora VK
Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):167-71. PubMed ID: 11036497
[TBL] [Abstract][Full Text] [Related]
6. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion.
Majumder V; Saha B; Hajra SK; Biswas SK; Saha K
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):283-90. PubMed ID: 11221091
[TBL] [Abstract][Full Text] [Related]
8. Light and electron microscopic study of peripheral nerve damage in patients with lepromatous leprosy (LL) and borderline lepromatous leprosy (BL).
Kajihara H; Paturusi IA; Saleh RM; Rasyad C; Ikuta Y
Hiroshima J Med Sci; 2000 Mar; 49(1):83-92. PubMed ID: 10824461
[TBL] [Abstract][Full Text] [Related]
9. Neural pathology in leprosy during treatment and surveillance.
Porichha D; Mukherjee A; Ramu G
Lepr Rev; 2004 Sep; 75(3):233-41. PubMed ID: 15508900
[TBL] [Abstract][Full Text] [Related]
10. Nasal mucosa and skin of smear-positive leprosy patients after 24 months of fixed duration MDT: histopathological and microbiological study.
Ebenezer GJ; Job A; Abraham S; Arunthathi S; Rao PS; Job CK
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):292-7. PubMed ID: 10575409
[TBL] [Abstract][Full Text] [Related]
11. The significance of changes in the nasal mucosa in indeterminate, tuberculoid and borderline leprosy.
Chacko CJ; Bhanu T; Victor V; Alexander R; Taylor PM; Job CK
Lepr India; 1979 Jan; 51(1):8-22. PubMed ID: 376945
[TBL] [Abstract][Full Text] [Related]
12. Are viable Mycobacterium leprae present in lepromatous patients after completion of 12 months' and 24 months' multi-drug therapy?
Ebenezer GJ; Daniel S; Norman G; Daniel E; Job CK
Indian J Lepr; 2004; 76(3):199-206. PubMed ID: 15835604
[TBL] [Abstract][Full Text] [Related]
13. The histopathology of lepromatous leprosy in the nose.
McDougall AC; Rees RJ; Weddell AG; Kanan MW
J Pathol; 1975 Apr; 115(4):215-26. PubMed ID: 1099180
[TBL] [Abstract][Full Text] [Related]
14. Histopathological lesions of apparently normal skin in leprosy patients.
Rashed HA; Mearag I; Saleh NM; Saied A
J Egypt Soc Parasitol; 2009 Dec; 39(3):933-42. PubMed ID: 20120756
[TBL] [Abstract][Full Text] [Related]
15. Analysis of gene probes and gene amplification techniques for diagnosis and monitoring of treatment in childhood leprosy.
Kamal R; Dayal R; Katoch VM; Katoch K
Lepr Rev; 2006 Jun; 77(2):141-6. PubMed ID: 16895070
[TBL] [Abstract][Full Text] [Related]
16. Histopathological study of apparently normal skin of patients with leprosy.
El-Darouti MA; Hussein S; Marzouk SA; Nabil N; Hunter NS; Mahgoub D; El-Eishi NH; Abdel-Halim MR
Int J Dermatol; 2006 Mar; 45(3):292-6. PubMed ID: 16533232
[TBL] [Abstract][Full Text] [Related]
17. [Hansen's disease: case report and review of literature].
Concha R M; Cossio T ML; Salazar S I; Fich S F; Pérez C C; González B S
Rev Chilena Infectol; 2008 Feb; 25(1):64-9. PubMed ID: 18273528
[TBL] [Abstract][Full Text] [Related]
18. Viability of Mycobacterium leprae in lepromatous patients after five years of dapsone monotherapy supplemented with two years of multidrug therapy.
Sivaprasad N; Snehalatha S; Lobo D; Aschhoff M; Job CK
Indian J Lepr; 1995; 67(4):427-33. PubMed ID: 8849919
[TBL] [Abstract][Full Text] [Related]
19. A controlled trial to compare the therapeutic effects of dapsone in combination with daily or once-monthly rifampin in patients with lepromatous leprosy.
Opromolla DV; Tonello CJ; McDougall AC; Yawalkar SJ
Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):393-7. PubMed ID: 7042603
[TBL] [Abstract][Full Text] [Related]
20. Two multidrug fixed-dosage treatment regimens with multibacillary leprosy patients.
Gallo ME; Alvim MF; Nery JA; Albuquerque EC; Sarno EN
Indian J Lepr; 1996; 68(3):235-45. PubMed ID: 8889609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
